What Researchers Did
The authors wrote a review of methaemoglobinaemia, a blood condition, covering its causes, diagnosis and treatment.
What They Found
This review describes methaemoglobinaemia, a condition in which an altered form of haemoglobin cannot bind oxygen, lowering the blood's oxygen-carrying capacity and causing potentially severe low oxygen levels and possible death. It arises from three main causes: mutations in globin genes (Haemoglobin-M), inherited deficiency of the enzyme cytochrome b5 reductase, and exposure to some oxidising agents such as dapsone and cocaine-derived anaesthetics. Patients are usually without symptoms when methaemoglobin is below 10 percent, and symptoms such as cyanosis, confusion, arrhythmias, coma and death appear as levels rise. Arterial blood gas values can look misleadingly normal, and the symptoms do not improve with supplemental oxygen. Intravenous methylene blue is the first-line treatment for symptomatic cases. Alternatives include high-dose vitamin C, exchange transfusion and potentially hyperbaric oxygen.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review rather than a trial, and the abstract itself says there is little evidence on how alternative therapies, including hyperbaric oxygen, should be used.